Definition and prevalence
Sleep disturbances in palliative care refer to a variety of conditions, including insomnia (difficulty initiating or maintaining sleep), hypersomnia (excessive sleepiness), sleep-disordered breathing (e.g., obstructive sleep apnoea), and circadian rhythm disruptions. These problems are prevalent among both patients and caregivers in palliative care, with causes often multifactorial, including physical, psychological, and environmental factors. [1]
Physical symptoms such as pain,
breathlessness, and nausea frequently contribute to disrupted sleep, especially in patients with advanced conditions like cancer, end-stage renal disease, and neurodegenerative diseases such as dementia. [2,3] Additionally, psychological factors such as anxiety,
depression, and existential distress are common in palliative care settings, further exacerbating sleep disturbances like insomnia. [1]
The prevalence of sleep disturbances is particularly high in this population. Between 50-80% of advanced cancer patients experience significant sleep disruptions, predominantly insomnia. [2,4] Similarly, over 60% of patients with end-stage renal disease experience sleep-disordered breathing and other sleep disruptions. Up to 60% of people living with dementia suffer from sleep issues including nocturnal agitation and excessive daytime sleepiness. [2,3] Caregivers, especially those caring for people living with dementia, are also highly susceptible to poor sleep, with approximately 70% reporting disrupted sleep due to emotional and physical caregiving burdens. [5,6]
Assessment
Assessing sleep disturbances in palliative care requires a holistic approach, considering both subjective and objective measures. Self-report tools, such as the Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI), are frequently used to gauge patients' sleep quality and identify specific disruptions. [1] These tools can be beneficial, yet their effectiveness may be limited in patients with cognitive impairments, such as those people living with advanced dementia. [2,3] In these cases, caregiver input becomes essential, particularly for monitoring nocturnal behaviours like wandering and agitation. [5,6]
For patients with advanced cancer, the assessment often focuses on identifying sleep-related issues linked to physical symptoms, including pain, breathlessness, and nausea. [2] Objective measures, for example, actigraphy or polysomnography, may provide valuable insights, particularly in detecting sleep-disordered breathing or fragmented sleep. [1] However, the feasibility of these assessments in a palliative care setting can be challenging, given the burden of illness and the limited availability of advanced diagnostic tools in many care environments.
In patients with neurodegenerative conditions, particularly dementia, assessments should consider both behavioural symptoms and the impact of circadian rhythm disturbances. [2,3] Informal caregiver reports are often important in such cases, as patients may be unaware of their sleep disruptions. [5,6] Additionally, non-verbal cues like restlessness or changes in night-time activity may be indicators of poor sleep quality, which standard assessment tools may not fully capture.
Non-pharmacological treatment
Non-pharmacological interventions are increasingly seen as valuable in managing sleep disturbances in palliative care, particularly due to the limitations of pharmacological treatments. Cognitive Behavioural Therapy for Insomnia (CBT-I) has been identified as a potentially effective approach, especially in cancer patients, as it targets the negative thought patterns and behaviours that contribute to poor sleep. [4] By doing so, CBT-I may reduce reliance on medications and improve overall sleep quality. [7] Physical activity, such as light to moderate exercise, has also been found to alleviate fatigue and pain, key factors in sleep disruption for patients in palliative care. [4]
Relaxation techniques, including mindfulness, meditation, and progressive muscle relaxation, have been associated with improvements in anxiety and sleep quality. These interventions are particularly useful for patients experiencing existential distress, as they may help reduce psychological discomfort and promote emotional well-being. [7, 8] While mindfulness-based therapies show promise for improving sleep, their effectiveness can depend on patient engagement and the complexity of the underlying condition. [1]
Environmental modifications can also play a key role in improving sleep, particularly in institutional care settings where disruptions are common. Ensuring a quiet, dark, and comfortable sleeping environment is important, especially for patients in hospital or care homes. [1] For individuals with dementia, maintaining consistent routines and reducing stimuli such as excessive light and noise may help manage nocturnal agitation. [3] Sensory interventions, such as the use of weighted blankets, are also being explored as potential strategies, though more research is needed to confirm their effectiveness across different patient groups. [7]
Pharmacological treatment
Pharmacological treatments are frequently employed in palliative care when sleep disturbances significantly affect quality of life and non-pharmacological approaches are insufficient. Benzodiazepines are widely used for their sedative and anxiolytic properties, helping to manage insomnia related to anxiety. However, long-term use is typically discouraged due to risks including dependence, cognitive impairment, and the potential for exacerbating sleep-disordered breathing, particularly in patients with respiratory conditions or frailty. [1,3] Careful consideration of dosage and patient condition is essential, particularly in elderly populations where side effects may be more severe. [8] If required for the treatment of insomnia, short-acting benzodiazepines are recommended in general. Currently, temazepam is the only benzodiazepine recommended for insomnia by Australian guidelines. [9]
Non-benzodiazepine hypnotics, such as zolpidem, are often viewed as alternatives, offering sleep benefits with a potentially lower risk of dependency. Nevertheless, these agents are not without concerns, as they can still lead to confusion or increased fall risk, especially in older adults. [1] Sedating antidepressants like mirtazapine are another option, particularly for patients experiencing concurrent depression or anxiety. Mirtazapine not only aids in improving sleep but may also address issues like poor appetite and low mood, making it suitable for palliative care patients with complex needs. [3]
Antipsychotic medications, such as quetiapine, are occasionally prescribed for patients experiencing severe agitation or hallucinations that interfere with sleep. These drugs can be helpful but carry risks of extrapyramidal side effects and cardiovascular issues, particularly in frail or elderly patients. [4] Melatonin, a hormone that regulates sleep-wake cycles, has also been considered for patients with circadian rhythm disruptions, although evidence supporting its effectiveness in palliative care remains limited. [7] The overall goal in pharmacological treatment is to balance efficacy with safety, particularly in a population that may be more vulnerable to adverse effects.
Sedating antihistamine diphenhydramine is a readily accessible over-the-counter sleep aid; however, it is not recommended for routine use in the palliative care setting particularly in patients with end-stage kidney disease as it is poorly dialysed. [10] This pre-disposes patients to anticholinergic side effects including delirium and increased risk of falls.